Results 31 to 40 of about 1,107,019 (331)
BMC Gastroenterology, 2018 Background Calprotectin is a stable neutrophil protein, which can be measured in faecal samples. The faecal level of calprotectin increases during disease activity in ulcerative colitis (UC).
Takahiro Shimoyama +3 more
doaj +1 more source
Review of the safety with biologics in inflammatory bowel disease
Journal of IMIDs, 2022 Biologics have completely changed the treatment (and life) of patients with inflammatory bowel disease (IBD). After the first ones, anti-tumor necrosis factor (TNF) biologics, two new biologics, with other therapeutic targets, are now in routine use in ...
Andrea Pascual +3 more
doaj +1 more source
Metalloproteinases in Inflammatory Bowel Diseases
Journal of Inflammation Research, 2021 Inflammatory bowel diseases (IBD) are chronic inflammatory diseases of the gastrointestinal tract, encompassing two main disorders: Crohn's disease (CD) and ulcerative colitis (UC). In both these pathologies, excessive and local immune response against luminal antigens promotes a pathological process leading to various degrees of gut damage.
Maronek M. +5 more
openaire +7 more sources
The Use of Oral Herbal Medicine (Hange-Shashin-To) in Patients with Pouchitis: A Pilot Study
Journal of the Anus, Rectum and Colon, 2018 Objectives: Hange-Shashin-To (HST), which is a combination of seven herbs, has previously been used in the treatment of inflammatory or ulcerative gut disease.
Hiroki Matsuoka +9 more
doaj +1 more source
Have advances in medical therapy for ulcerative colitis impacted surgical treatment?
Annals of Gastroenterological Surgery, 2023 Aim The purpose of this study was to examine how the clinical characteristics, indications for surgery, and postoperative course of ulcerative colitis (UC) surgical patients changed before and after the introduction of biological agents. Methods Patients
Ryuichi Kuwahara +5 more
doaj +1 more source
Pouchitis in inflammatory bowel disease: a review of diagnosis, prognosis, and treatment [PDF]
Intestinal Research, 2021 Patients with inflammatory bowel disease (IBD) occasionally need a restorative proctocolectomy with ileal pouch-anal anastomosis (IPAA) because of medically refractory colitis or dysplasia/cancer.
Shintaro Akiyama +2 more
doaj +1 more source
Evidence-based clinical practice guidelines for inflammatory bowel disease 2020
Journal of gastroenterology, 2021 Inflammatory bowel disease (IBD) is a general term for chronic or remitting/relapsing inflammatory diseases of the intestinal tract and generally refers to ulcerative colitis (UC) and Crohn’s disease (CD).
H. Nakase +23 more
semanticscholar +1 more source
Clinical and Translational Medicine, 2022 G protein‐coupled receptor 65 (GPR65), a susceptibility gene for inflammatory bowel diseases (IBD), has been identified to promote Th17 cell pathogenicity and induce T cell apoptosis.
Ritian Lin +9 more
doaj +1 more source
Gut microbiome structure and metabolic activity in inflammatory bowel disease
Nature Microbiology, 2018 The inflammatory bowel diseases (IBDs), which include Crohn’s disease (CD) and ulcerative colitis (UC), are multifactorial chronic conditions of the gastrointestinal tract.
E. Franzosa +26 more
semanticscholar +1 more source
Cytokines in inflammatory bowel disease [PDF]
Mediators of Inflammation, 1997 Over the past decade, much has been learned regarding the role of various cytokines in the pathogenesis of inflammatory bowel disease. Several cytokine ‘knockout’ models in mice have been shown to develop colitis, while alterations in the production of various cytokines has been documented in human Crohn′s disease and ulcerative colitis.
Beck, P. L., Wallace, J. L.
openaire +5 more sources